Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.76% Profit

May 14, 2025
On April 15, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.35. Analysts predicted a downward movement in the stock price. Fast forward to May 14, 2025, and the stock reached the target price of $43.55, yielding a profit of 11.76% for investors who followed the forecast.

This achievement highlights the accuracy and reliability of QuantWave's analytics in predicting stock movements. The success of this forecast demonstrates the platform's capability to guide investors in making profitable decisions in the market.

Factors contributing to the stock's movement may include changes in market sentiment towards the pharmaceutical industry, company-specific news, or broader economic conditions impacting the healthcare sector. QuantWave's advanced algorithms analyze various data points to provide valuable insights for traders and investors.

QuantWave offers users access to predictions for a wide range of stocks, presenting opportunities for potential profits. For those interested in learning more about the investment strategy behind QuantWave, QuantSchool provides comprehensive educational resources. This platform reveals the key principles for generating consistent income using QuantWave's forecasting system, empowering investors to make informed decisions in the market.
If you want to leave a comment, then you need Login or Register





Other data for BMY

Related data

BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....

BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Price Target with 9.09% Profit: QuantWave Forecast Success  ~2 min.

On April 23, 2025, QuantWave's forecasting platform generated a short signal for BRISTOL-MYERS SQUIBB COMPANY stock, which was trading at $47.9 at the time....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 12.75% Profit - QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY recently achieved the price target forecast set by QuantWave, resulting in a profitable outcome of 12.75%....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.87% Profit  ~1 min.

On May 5, 2025, QuantWave issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.41. The forecast proved accurate as the price target of $43....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Target Forecast with 13.0% Profit - QuantWave Analysis  ~1 min.

On April 11, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price of $50.05....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 10.38% Profit: QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY, a renowned pharmaceutical company, recently achieved its price target forecast set by QuantWave's automated forecasting platform....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 14.06% Profit  ~1 min.

On April 14, 2025, QuantWave's forecast signal indicated a short position for BRISTOL-MYERS SQUIBB COMPANY stock, which was priced at 50.67 $....

REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis  ~1 min.

In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....

PFEJuly 26, 2024Price Target Forecast Success: PFIZER INC. Achieves 14.81% Profit as Predicted by QuantWave  ~1 min.

In a significant win for QuantWave's analytics, the stock of PFIZER INC. has successfully reached the forecasted price target with a profit of 14.81%....

LLYMay 3, 2023ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 19.14% Profit Gain  ~2 min.

ELI LILLY AND COMPANY's stock has successfully achieved the price target forecast set by QuantWave, resulting in a profit gain of 19.14%. The forecast signal was given on January 4, 2023, with a price of 355....

ABBVAugust 15, 2024ABBVIE INC. Hits Price Target Forecast on QuantWave with 11.7% Profit  ~2 min.

On July 23, 2024, QuantWave's automated forecasting platform issued a long signal for ABBVIE INC. (ABBV), with the stock trading at 168.62 $....

ABTJanuary 24, 2025ABBOTT LABORATORIES Stock Hits Forecast Target with Profit of 15.68%  ~1 min.

On January 24, 2023, QuantWave issued a long signal for ABBOTT LABORATORIES stock when it was trading at 107.59 $....